GlassScriptPhysician profile
Aisha Hasan
NPI 1396098505
$1,513.39
in general payments reported to CMS, 2019-2025
12 companies · $1,019 in 2025
The $1,019 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $66.43 · 2023: $57.66 · 2024: $371 · 2025: $1,019.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,446.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $813.37 | 2024-2025 | |
| Revance Therapeutics, INC. | $316.99 | 2025 | Daxxify, Daxi |
| Medtronic, INC. | $118.34 | 2024 | Intellis Adaptivestim |
| Galderma Laboratories, L.P. | $64.07 | 2025 | |
| Horizon Therapeutics Plc | $38.55 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $38.47 | 2023-2024 | Zilretta, Iovera, Exparel |
| Fidia Pharma USA INC. | $27.88 | 2022 | |
| Curonix LLC | $27.16 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spr Therapeutics, INC | $21.47 | 2023 | Sprint Pns System |
| Convatec INC. | $16.43 | 2024 | |
| Neurocrine Biosciences, INC. | $15.58 | 2023 | Ingrezza |
| Avanos Medical | $15.08 | 2024 | On-Q* Pump and Accessories |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aisha Hasan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.